ARA-290 is an investigational erythropoietin-derived peptide studied for activation of the innate repair receptor. Human research has primarily evaluated its effects on small-fiber neuropathy, sensory and autonomic symptoms, neuroinflammatory signaling, and small-nerve-fiber abundance in sarcoidosis and type 2 diabetes.

Item is shipped lyophilized so will need to be reconstituted with BAC water which is purchased separately.